USPTO serial 99276215
HERACURE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- HARMON KENNEDY, HEATHER N
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).
Need help with HERACURE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Holly M. Ford Lewis
Holly M. Ford Lewis Panitch Schwarze Belisario & Nadel LLP2005 Market Street, Suite 3325One Commerce SquarePhiladelphia, PA 19103Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Veterinary pharmaceutical preparations for the treatment of orthopedic and traumatological diseases; Medical preparations for the treatment of orthopedic and traumatological diseases; Pharmaceutical preparations for the treatment of orthopedic and traumatological diseases; Pharmaceutical preparations for the treatment of dental bone diseases, namely, injectors sold filled with implantable dental bone void fillers comprised of living tissues; Sanitary preparations for medical purposes; Bone cements for surgical purposes; Bone cements for orthopaedic purposes; Bone cement for medical purposes; Bone void fillers consisting of natural materials; Bone void fillers comprised of living tissues; Bone fillers consisting of living materials; Bone cement for surgical and orthopaedic purposes; Pharmaceutical preparations for the treatment of bone fractures; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical preparations for the treatment of bone diseases; Synthetic material for use in setting bones, namely, bone void fillers consisting primarily of biological materials and also incorporating synthetic materials; Bone growth media consisting of biological materials for medical purposes; Anti-bacterial preparations, namely, antibacterial substances for medical purposes; Antiseptics; Antiseptics with prophylactic effect; Antiseptics with therapeutic effect; Bactericides; Disinfectants; Disinfectants for medical use; Germicides; Germicidal preparations; Sterilising substances; Sterilizing preparations; Anti-inflammatory preparations; Antibiotics; Pain relief preparations; Biological implants, namely, a vital processed human or animal connective tissue | ACTIVE | — |
| 010 | Surgical apparatus and instruments; Dental apparatus and instruments, namely, delivery devices for dispensing implantable materials, namely, syringes, sold empty; Medical apparatus and instruments for the treatment of orthopedic and traumatological diseases; Artificial limbs; Artificial teeth; Artificial eyes; Bone substitutes for surgical use; Bone implants composed of artificial materials; Bone void fillers comprised of artificial materials; Bone prostheses; Osseous implants made of artificial materials; Synthetic bone graft substitutes; Artificial bone materials, namely, Bone implants composed of artificial materials; artificial bone implants for bone surgery made of artificial materials; Biodegradable bone fixation implants made of artificial materials; artificial bone implants for use in bone grafting made of artificial materials | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 22, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 22, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 16, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 26, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Aug 26, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 26, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 26, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Aug 26, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 8, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 8, 2026 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Jun 8, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 8, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 29, 2026 | GEAN | NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | — |
| May 29, 2026 | GEAP | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | — |
| May 29, 2026 | EPEN | COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY | — |
| May 29, 2026 | CPEA | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED | — |
| Apr 13, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 24, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 23, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 23, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 24, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 24, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 24, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 24, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 14, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 10, 2025 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Oct 10, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 10, 2025 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Oct 10, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 10, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 10, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 10, 2025 | NWAP | NEW APPLICATION ENTERED | — |